Skip to main content
logo
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.7154
+0.0116 (1.65%)
At close: Apr 2, 2026, 4:00 PM EDT
0.6706
-0.0448 (-6.26%)
After-hours: Apr 2, 2026, 7:55 PM EDT

Aprea Therapeutics Revenue

In the year 2025, Aprea Therapeutics had annual revenue of $285.76K, down -80.98%. Aprea Therapeutics had revenue of $3.34K in the quarter ending December 31, 2025, a decrease of -98.38%.

Revenue (ttm)
$285.76K
Revenue Growth
-80.98%
P/S Ratio
28.67
Revenue / Employee
$35,720
Employees
8
Market Cap
8.19M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025285.76K-1.22M-80.98%
Dec 31, 20241.50M919.35K157.63%
Dec 31, 2023583.23K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

APRE News

More News